Organization
Our core values
Committed
Our care is characterized by personal attention, warm and professional involvement and sincerity. We ensure that the treatment meets the needs, wishes and preferences of our patients, and together we arrive at a tailor-made treatment.
Excellent
We aim for the optimal result, both in the care of our patients and in our research. Based on the latest proven insights, we offer the best possible treatment result and the best possible quality of life. Our researchers work every day to better understand how cancer develops and how we can cure it.
Groundbreaking
We are groundbreaking in our care and our research. This means that, if it is in the interest of our patients, we can think and act outside the box. We are constantly looking for improvement and innovation. We think ahead and see opportunities.
Together
Providing top care and top research means working together. Our lines of communication are short. We think in terms of solutions, possibilities and innovation. We think it is important to make a choice together with our patients for a treatment, or a combination of treatments in our hospital.
Governance and Organization
Board of Directors Antoni van Leeuwenhoek
The Board of Directors is ultimately responsible for the strategy, policy, financing and the realisation of the organisational objectives of the Netherlands Cancer Institute. View the organization's organization chart here
The Board of Directors can be reached via raadvanbestuur@nki.nl
Supervisory Board

The Supervisory Board is an expert in the following areas: governance, research, patient care, financial-economic and legal affairs. A strong composition of the Supervisory Board will benefit the position of the Netherlands Cancer Institute. The Supervisory Board fully supervises the management of the Board of Directors, the policy of the Board of Directors and the general affairs of the foundation and the associated institutions. The Supervisory Board assists the Board of Directors with advice. The Supervisory Board consists of:
- Mr. mr. P.C.J. van der Slikke, chairman of the Supervisory Board
- Mrs. Prof. A.G.M. Schilder, member of the quality committee
- Prof. M.J. Heineman, Chairman of the Quality Committee
- Mr M.P. Lap, member of the audit committee
- Prof. M.M . Levi, Chairman of the Audit Committee
- Ms H. Uhlenbroek, Vice-Chair and Chair of the Remuneration Committee
If you have any questions or comments , please contact the Executive Board / Supervisory Board via Dr M.J. Blaauw (secretary of the Executive Board and Supervisory Board).
Supervisory vision Supervisory Board 2021
Schedule of resignation of the Supervisory Board
The Supervisory Board can be reached via: raadvantoezicht@nki.nl
Board of Medical Staff
- Dr. L. Hulshoff, anaesthesiologist (chairman)
- Dr. J.M. de Feijter, internist (secretary)
- Dr. W.V. Vogel, radiation oncologist, nuclear medicine physician (member)
- A. W. Buddeke, anaesthesiologist (member)
- Dr. H.H. van Rossum, clinical chemist (member)
- Dr. E. J. Rijkhorst, clinical physicist (member)
- Dr. N.E. van Trommel, gynaecologist (member)
- P. Ebbinkhuijsen, official secretary (bestuurmedischestaf@nki.nl)
Governance
- Read more about our environmental and sustainability policy here .
- Read more about the board costs here .
- Read more about the Healthcare Governance Code and the Netherlands Code of Conduct for Research Integrity that the Netherlands Cancer Institute follows here.
- Read the Board of Directors regulations here.
- Read the Supervisory Board regulations here .
Annual reports
- Management Report and Financial Statements 2024 PDF [1.9 MB]
- Management Report and Financial Statements 2023 PDF [1.9 MB]
- Management report and financial statements 2022 PDF [4 MB]
- Financial statements 2021 PDF [1.4 MB]
- Financial statements 2020 PDF [872 KB]
- Financial statements 2019 PDF [593 KB]
ANBI information
The NKI-AVL Foundation is an ANBI, a Public Benefit Institution. This means that donations to our foundation are tax deductible under certain conditions. Below you will find our RSIN number and our ANBI annual account.
RSIN number: 002562169
- ANBI Publication Obligation Form 2024 PDF [340 KB]
- ANBI Publication Obligation Form 2023 PDF [237 KB]
- ANBI Publication Obligation Form 2022 PDF [204 KB]
- ANBI Publication Obligation Form 2021 PDF [99 KB]
- ANBI form publication obligation 2020 PDF [280 KB]
Important cooperation partners
- KWF Cancer Society
- EU-LIFE
- Cancer Core Europe
- Center for Personalised Cancer Treatment (CPCT)
Oncode Institute - Organization of European Cancer Institutes (OECI)
- AI technology for people
- Dutch Federation of Cancer Patient Associations (NFK) and Patient Associations in the Field of Cancer
- We work together with almost all universities and medical centers, including the Amsterdam UMC and within various networks such as the prostate cancer network and the CGOA in the field of gynaecological cancer.
- We have a consultation function in the field of cancer at many hospitals in the Netherlands
nl